News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech
Spotlight

home
Topic
Glenmark pharmaceuticals

Glenmark Pharmaceuticals

Glenmark To Pay $87.5 Millon To Settle Lawsuits Over A Product In US

Glenmark To Pay $87.5 Millon To Settle Lawsuits Over A Product In US

BY Press Trust of India

Glenmark Pharmaceuticals Get USFDA Nod For Human Trial Of Advanced Cancer-Treating Drug

Glenmark Pharmaceuticals Get USFDA Nod For Human Trial Of Advanced Cancer-Treating Drug

BY Press Trust of India

Glenmark And Cediprof Announce Exclusive Distribution Agreement In US

Glenmark And Cediprof Announce Exclusive Distribution Agreement In US

BY Press Trust of India

Glenmark Gets USFDA Nod For Generic Diabetes Drug

Glenmark Gets USFDA Nod For Generic Diabetes Drug

BY Press Trust of India

USFDA Gives Exception To Glenmark Pharma To Supply Pneumonia Drug From Baddi Facility

USFDA Gives Exception To Glenmark Pharma To Supply Pneumonia Drug From Baddi Facility

BY Press Trust of India

Glenmark Pharma

USFDA Issues Import Alert On Glenmark Pharma's Baddi Plant

BY Press Trust of India

These are generic versions of Vimpat tablets of the corresponding strengths of UCB, Inc.

Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

BY Press Trust of India

Advertisement

Limited Upside for Glenmark Pharmaceuticals

Limited Upside for Glenmark Pharmaceuticals

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2024 Outlook Publishing India Pvt Ltd.

Copyright © 2024 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.